Search results for "Perte"

showing 10 items of 1643 documents

A rare case of infrarenal aortic coarctation in a young female

2020

Abstract Introduction Infrarenal abdominal aortic coarctation (AAC) is an extremely rare disease. It can be associated with renal artery stenosis determining secondary renal hypertension. Presentation of case We report a case of AAC in young female patient presenting systemic hypertension non-responder to medical treatment. Diagnostics revealed the involvement of the right renal artery as the cause of hypertension. The management consisted of percutaneous renal artery stenting and close surveillance for the aortic segment. The treatment was uneventful with resolution of the hypertensive condition. Discussion AAC etiology is unknown. There are no studies comparing the long-term treatment out…

medicine.medical_specialtyPercutaneousSecondary hypertensionRenal artery stenosisSettore MED/22 - Chirurgia VascolareAortic coarctation03 medical and health sciences0302 clinical medicinemedicine.arteryInternal medicineCase reportmedicineRenal stentingRight Renal ArteryRenal arteryPercutaneousAortic SegmentEndovascularbusiness.industrymedicine.diseaseSecondary hypertension030220 oncology & carcinogenesisCardiologyEtiology030211 gastroenterology & hepatologySurgerybusinessRare disease
researchProduct

European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement

2003

IntroductionOver the past 20 years or so, the accuracy of the conventional Riva-Rocci/Korotkoff technique of blood pressure measurement has been questioned and efforts have been made to improve the technique with automated devices. In the same period, recognition of the phenomenon of white-coat hype

medicine.medical_specialtyPhysiologyBlood PressureSphygmomanometer030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineInternal MedicinemedicineHumansBlood pressure monitoring030212 general & internal medicineHypertension diagnosisIntensive care medicineSocieties MedicalMicrolifebusiness.industryBlood Pressure Monitoring AmbulatoryEuropeSelf CareMasked HypertensionBlood pressureCardiovascular DiseasesHypertensionAmbulatorySelf careCardiology and Cardiovascular MedicinebusinessJournal of Hypertension
researchProduct

European Society of Hypertension Working Group on Obesity Obesity-induced hypertension and target organ damage: current knowledge and future directio…

2009

medicine.medical_specialtyPhysiologyCardiomegalyKidneyCardiovascular SystemDiabetes ComplicationsRisk FactorsDiabetes ComplicationInternal medicineInternal MedicinemedicineAlbuminuriaHumansObesityIntensive care medicineHeart FailureInflammationbusiness.industryRisk Factormedicine.diseaseTarget organ damageObesityHeart failureHypertensionCardiologyCardiology and Cardiovascular MedicinebusinessHumanJournal of hypertension
researchProduct

Damage-associated molecular pattern activated Toll-like receptor 4 signalling modulates blood pressure in L-NAME-induced hypertension

2013

Aims Recent publications have shed new light on the role of the adaptive and innate immune system in the pathogenesis of hypertension. However, there are limited data whether receptors of the innate immune system may influence blood pressure. Toll-like receptor 4 (TLR4), a pattern recognition receptor, is a key component of the innate immune system, which is activated by exogenous and endogenous ligands. Hypertension is associated with end-organ damage and thus might lead to the release of damage-associated molecular patterns (DAMPs), which are endogenous activators of TLR4 receptors. The present study aimed to elucidate whether TLR4 signalling is able to modulate vascular contractility in …

medicine.medical_specialtyPhysiologyMedizinInflammationBiologyContractilityMicePhysiology (medical)Internal medicinemedicineAnimalsReceptorCyclic GMPInflammationToll-like receptorInnate immune systemPattern recognition receptorDamage-associated molecular patternCell biologyMice Inbred C57BLToll-Like Receptor 4EndocrinologyNG-Nitroarginine Methyl EsterHypertensionTLR4Blood Vesselsmedicine.symptomCardiology and Cardiovascular MedicineSignal Transduction
researchProduct

The metabolic syndrome in hypertension: European society of hypertension position statement.

2008

The metabolic syndrome considerably increases the risk of cardiovascular and renal events in hypertension. It has been associated with a wide range of classical and new cardiovascular risk factors as well as with early signs of subclinical cardiovascular and renal damage. Obesity and insulin resistance, beside a constellation of independent factors, which include molecules of hepatic, vascular, and immunologic origin with proinflammatory properties, have been implicated in the pathogenesis. The close relationships among the different components of the syndrome and their associated disturbances make it difficult to understand what the underlying causes and consequences are. At each of these …

medicine.medical_specialtyPhysiologySodium Chloride Symporter InhibitorsAdrenergic beta-AntagonistsPhysical exerciseAngiotensin-Converting Enzyme InhibitorsType 2 diabetesBioinformaticsInsulin resistanceWeight lossInternal medicineInternal MedicinemedicineHumansThiazideAntihypertensive AgentsMetabolic Syndromebusiness.industrymedicine.diseaseCalcium Channel BlockersObesityExercise TherapyEndocrinologyBlood pressureHypertensionmedicine.symptomMetabolic syndromeCardiology and Cardiovascular MedicinebusinessAngiotensin II Type 1 Receptor BlockersRisk Reduction Behaviormedicine.drugDiet TherapyJournal of hypertension
researchProduct

Practical solutions to the challenges of uncontrolled hypertension: a white paper.

2008

This white paper is an urgent call to action from aninternational group of physicians. The continued failure tocontrolhypertensiontakesanunacceptabletollon patients,families and society and it must be addressed. Any patientwith blood pressure of 140/90 mmHg or greater can becharacterizedasa ‘challengingpatient’,is atsignificant risk,and requires persistent optimization of therapy until targetblood pressure is achieved. Six key challenges in reachingthis goal blood pressure are described: (1) inadequateprimary prevention; (2) faulty awareness of risk; (3) lack ofsimplicity; (4) therapeutic inertia; (5) insufficient patientempowerment; and (6) unsupportive healthcare systems.This white paper id…

medicine.medical_specialtyPhysiologybusiness.industryCall to actionWhite paperBlood pressureHealth careHypertensionInternal MedicinemedicineHumansCardiology and Cardiovascular MedicineIntensive care medicinebusinessAntihypertensive AgentsNeeds AssessmentJournal of hypertension. Supplement : official journal of the International Society of Hypertension
researchProduct

2021 European Society of Hypertension practice guidelines for office and out-of-office blood pressure measurement.

2021

High blood pressure (BP) is the leading modifiable risk factor for morbidity and mortality worldwide. The basis for diagnosing and managing hypertension is the measurement of BP, which is routinely used to initiate or rule out costly investigations and long-term therapeutic interventions. Inadequate measurement methodology or use of inaccurate BP measuring devices can lead to overdiagnosis and unnecessary treatment, or underdiagnosis and exposure to preventable cardiovascular disease (CVD). [...]

medicine.medical_specialtyPhysiologybusiness.industryMEDLINEBlood PressureBlood Pressure Determination030204 cardiovascular system & hematologyBlood Pressure Monitoring Ambulatory03 medical and health sciences0302 clinical medicineBlood pressureEmergency medicineAmbulatoryHypertensionInternal MedicinemedicineHumansBlood pressure monitoring030212 general & internal medicineHypertension diagnosisCardiology and Cardiovascular Medicinebusiness
researchProduct

Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement.

2005

Introduction Blood pressuremeasurement is the basis for the diagnosis, management, treatment, epidemiology and research of hypertension, and the decisions affecting these aspects of hypertensionwill be influenced, for better or worse, by the accuracyofmeasurement.Anaccuratebloodpressure reading is a prerequisite, therefore, regardless of which technique is used, yet all too often the accuracy of measurement is taken for granted or ignored. This paper is a summary up-dated version of the recommendations published by the European Society of Hypertension (ESH) Working Group on Blood Pressure Monitoring for conventional (CBPM), ambulatory (ABPM) and self (SBPM) blood pressure measurement in 200…

medicine.medical_specialtyPhysiologybusiness.industryMEDLINESphygmomanometerGuidelineBlood Pressure Monitoring AmbulatoryAmbulatory care nursingEuropeSelf CareBlood pressureEpidemiologyAmbulatoryHypertensionInternal MedicinemedicineHumansBlood pressure monitoringCardiology and Cardiovascular MedicinebusinessIntensive care medicineHumanJournal of hypertension
researchProduct

Direct and surrogate measures of the white-coat effect: Methodological aspects and clinical relevance

2000

medicine.medical_specialtyPhysiologybusiness.industryOffice VisitsOffice visitsMEDLINEBlood Pressure DeterminationPrognosisOrgan damageBlood pressureAmbulatoryHypertensionInternal MedicineMedicineHumansClinical significanceOffice VisitCardiology and Cardiovascular MedicinebusinessIntensive care medicineWhite coat effectHuman
researchProduct

Hypertension and atrial fibrillation: diagnostic approach, prevention and treatment. Position paper of the Working Group 'Hypertension Arrhythmias an…

2012

Hypertension is the most common cardiovascular disorder and atrial fibrillation is the most common clinically significant arrhythmia. Both these conditions frequently coexist and their prevalence increases rapidly with aging. There are different risk factors and clinical conditions predisposing to the development of atrial fibrillation, but due its high prevalence, hypertension is still the main risk factor for the development of atrial fibrillation. Several pathophysiologic mechanisms (such as structural changes, neurohormonal activation, fibrosis, atherosclerosis, etc.) have been advocated to explain the onset of atrial fibrillation. The presence of atrial fibrillation per se increases th…

medicine.medical_specialtyPhysiologymacromolecular substancesFibrosisRisk FactorsCardiovascular DisorderInternal medicineThromboembolismAtrial FibrillationInternal MedicinemedicineHumanscardiovascular diseasesRisk factorStrokeSocieties Medicalbusiness.industryWarfarinAtrial fibrillationHypertension atrial fibrillation anticoagulants antihypertensive treatmentMED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLAREmedicine.diseaseThrombosisEuropeBlood pressureHypertensionCardiologyCardiology and Cardiovascular Medicinebusinessmedicine.drugJournal of hypertension
researchProduct